Results 251 to 260 of about 155,675 (375)

CT in the clinical and prognostic evaluation of acute graft-vs-host disease of the gastrointestinal tract [PDF]

, 2012
Avichai Shimoni, Uri Rimon, M. Hertz, Ronit Yerushalmi, Michal Amitai, Orith Portnoy, Larisa Guranda, Arnon Nagler, Sara Apter   +8 more
openalex   +1 more source

Amphiregulin modifies the Minnesota acute graft-versus-host disease risk score: Results from BMT CTN 0302/0802 [PDF]

, 2018
Pusic, Iskra
core   +1 more source

Long‐term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium

British Journal of Haematology, EarlyView.
The overall survival of patients receiving an allogeneic haematopoietic stem cell transplant (HSCT) for GATA2 deficiency was significantly better if they were transplanted recently, with a bone marrow or cord blood graft and if the transplant was performed before the onset of excess blast. Excess blast before HSCT was the only factor associated with an
Flore Sicre de Fontbrune, Florian Chevillon, Mony Fahd, Kristell Desseaux, Xavier Poiré, Edouard Forcade, Arthur Sterin, Bénédicte Neven, Virginie Gandemer, Sylvain Thepot, Alice Garnier, Bruno Lioure, Ambroise Marcais, Stephanie Nguyen‐Quoc, Suzanne Tavitian, Laure Vincent, Jean Donadieu, Matthieu Resche Riggon, Sylvie Chevret, Marlene Pasquet, Regis Peffault de Latour   +20 more
wiley   +1 more source

Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease. [PDF]

J Health Econ Outcomes Res
Peacock A, Dehle FC, Mesa Zapata OA, Gennari F, Williams MRI, Hamad N, Larsen S, Harrison SJ, Taylor C.   +8 more
europepmc   +1 more source

306: Successful phase II trial using mesenchymal stem cells (MSC) in combination with steroid therapy for the primary treatment of acute graft-vs-host disease (aGVHD)

, 2007
P. Kebriaei, L. M. Isola, Erkut Bahceci, H.K. Holland, Scott D. Rowley, Joseph P. McGuirk, Marcel P. Devetten, Jan B.�M.�J. Jansen, RH Herzig, M. Schuster, Joseph P. Uberti   +10 more
openalex   +1 more source

Gene expression profiling of acute graft-vs-host disease after hematopoietic stem cell transplantation [PDF]

, 2012
Jan Verner, Jitka Kabáthová, Alexandra Tomancová, Šárka Pavlová, Boris Tichý, Marek Mráz, Yvona Brychtová, Marta Krejčí, Zbyněk Zdráhal, Martin Trbušek, Jana Volejníková, Petr Sedláček, Michael Doubek, Jiřı́ Mayer, Šárka Pospı́šilová   +14 more
openalex   +1 more source

Indirect presentation of mismatched human leukocyte antigen‐B associates with outcomes of cord blood transplantation

British Journal of Haematology, EarlyView.
This study analysed 1498 single‐unit cord blood transplantation (CBT) cases (2000–2018) to evaluate the impact of mismatched human leukocyte antigen (HLA) immunogenicity. Results highlighted that Class I epitopes from recipient‐mismatched HLA‐B were associated with higher transplantation‐related mortality (TRM) and lower neutrophil engraftment ...
Takeshi Sugio, Kohta Miyawaki, Naoyuki Uchida, Matthias Niemann, Eric Spierings, Kyohei Mori, Yuju Ohno, Tetsuya Eto, Yasuo Mori, Goichi Yoshimoto, Yoshikane Kikushige, Yuya Kunisaki, Shinichi Mizuno, Koji Nagafuji, Hiromi Iwasaki, Tomohiko Kamimura, Ryosuke Ogawa, Toshihiro Miyamoto, Shuichi Taniguchi, Koichi Akashi, Koji Kato   +20 more
wiley   +1 more source

Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial. [PDF]

Int J Hematol
Teshima T, Onishi Y, Kato K, Taniguchi S, Miyamura K, Fukushima K, Kato J, Ishikawa T, Doki N, Nakamae H, Maeda Y, Inamoto Y, Okada M, Maki A, Shimada F, Tajima T, Wroclawska M, Zeiser R, Onizuka M.   +18 more
europepmc   +1 more source

Antibiotic administration exacerbates acute graft vs. host disease-induced bone marrow and spleen damage in lymphopenic mice. [PDF]

PLoS One, 2021
McDaniel Mims B, Enriquez J, Pires Dos Santos A, Jones-Hall Y, Dowd S, Furr KL, Grisham MB.   +6 more
europepmc   +1 more source